Zobrazeno 1 - 10
of 735
pro vyhledávání: '"N, Savani"'
Autor:
Marion Larue, Myriam Labopin, Thomas Schroeder, Xiao‐jun Huang, Igor W. Blau, Johannes Schetelig, Arnold Ganser, Rose‐Marie Hamladji, Wolfgang Bethge, Nicolaus Kröger, Gerard Socié, Urpu Salmenniemi, Henrik Sengeloev, Bhagirathbhai Dholaria, Bipin N. Savani, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Publikováno v:
HemaSphere, Vol 8, Iss 10, Pp n/a-n/a (2024)
Abstract Information on late complications in patients with acute leukemia who have undergone allogeneic hematopoietic cell transplantation (HCT) is limited. We performed a left‐truncated analysis of long‐term survival in patients with acute leuk
Externí odkaz:
https://doaj.org/article/09c3faec71ba4764a35435dfe6de6cda
Publikováno v:
eJHaem, Vol 3, Iss S1, Pp 11-23 (2022)
Abstract CD19‐directed chimeric antigen receptor T‐cell therapy (CAR‐T) represents a significant advancement for patients with relapsed/refractory large B‐cell lymphoma (LBCL). Long‐term follow‐up confirms durable remissions in nearly hal
Externí odkaz:
https://doaj.org/article/1bac588c5afd46b5b7eac3a06bf8c6f2
Autor:
Shakthi T. Bhaskar, Bhagirathbhai R. Dholaria, Salyka M. Sengsayadeth, Bipin N. Savani, Olalekan O. Oluwole
Publikováno v:
eJHaem, Vol 3, Iss S1, Pp 39-45 (2022)
Abstract Chimeric antigen receptor (CAR) T‐cell therapy has been approved for use in several relapsed/refractory hematologic malignancies and has significantly improved outcomes for these diseases. A number of different CAR T products are now being
Externí odkaz:
https://doaj.org/article/200393726d9643079db7bb40b864df68
Autor:
Urvi Patel, John Abernathy, Bipin N Savani, Olalekan Oluwole, Salyka Sengsayadeth, Bhagirathbhai Dholaria
Publikováno v:
eJHaem, Vol 3, Iss S1, Pp 24-31 (2022)
Abstract Chimeric antigen receptor (CAR) T cell therapy has made tremendous strides in the arena of hematological malignancies with approved therapies in certain leukemias, lymphomas, and recently myeloma with overall highly favorable response rates.
Externí odkaz:
https://doaj.org/article/a12c104bdc4c4766a544ea4176e6e291
Publikováno v:
eJHaem, Vol 3, Iss S1, Pp 6-10 (2022)
Abstract In recent years, we have seen rapid expansion of chimeric antigen receptor T‐cell (CAR‐T) therapies in multiple malignancies. CAR‐T therapy has profoundly altered the treatment landscape of non‐Hodgkin lymphoma, B‐cell acute lympho
Externí odkaz:
https://doaj.org/article/ccade5645d4a491f95039d9869a33079
Autor:
Katie S. Gatwood, Bhagirathbhai R. Dholaria, Mariana Lucena, Brittney Baer, Bipin N. Savani, Olalekan O. Oluwole
Publikováno v:
eJHaem, Vol 3, Iss S1, Pp 54-60 (2022)
Abstract Adoptive cellular therapy has made a landmark change within the treatment paradigm of several hematologic malignancies, and novel cellular therapy products, such as chimeric antigen receptor T‐cell therapy (CART), have demonstrated impress
Externí odkaz:
https://doaj.org/article/00008ecd51d54b89bab703d8e5bdaba3
Autor:
Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal, Talha Badar, Sherif M. Badawy, Karen Ballen, Amer Beitinjaneh, Jan Cerny, Saurabh Chhabra, Zachariah DeFilipp, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, Shatha Farhan, Cesar O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Vikas Gupta, Michael R. Grunwald, Nada Hamad, Gerhard C. Hildebrandt, Yoshihiro Inamoto, Tania Jain, Omer Jamy, Mark Juckett, Matt Kalaycio, Maxwell M. Krem, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Guillermo Ortí, Sagar S. Patel, Marjolein van der Poel, David A. Rizzieri, Bipin N. Savani, Sachiko Seo, Melhem Solh, Leo F. Verdonck, Baldeep Wirk, Jean A. Yared, Ryotaro Nakamura, Betul Oran, Bart Scott, Wael Saber
Publikováno v:
Haematologica, Vol 108, Iss 7 (2023)
Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative treatment for myelofibrosis. However, the optimal conditioning regimen either with reduced-intensity conditioning (RIC) or myeloablative conditioning (MAC) is not well
Externí odkaz:
https://doaj.org/article/3607fa3e9937487db3f85032af240a0d
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 607-615 (2021)
Abstract Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are clonal myeloid malignancies that are characterized by dysplasia resulting in cytopenias as well as proliferative features such as thrombocytosis or splenomegaly. Recent studies have
Externí odkaz:
https://doaj.org/article/a8a79a5c2d7748de84c52249791671fb
Publikováno v:
eJHaem, Vol 3, Iss S1, Pp 3-5 (2022)
Externí odkaz:
https://doaj.org/article/4bdde2ea658449dd907dc99256edc901
Autor:
Bhagirathbhai Dholaria, Myriam Labopin, Jaime Sanz, Annalisa Ruggeri, Jan Cornelissen, Hélène Labussière-Wallet, Didier Blaise, Edouard Forcade, Patrice Chevallier, Anna Grassi, Ludmila Zubarovskaya, Jürgen Kuball, Patrice Ceballos, Fabio Ciceri, Frederic Baron, Bipin N. Savani, Arnon Nagler, Mohamad Mohty
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-11 (2021)
Abstract Background Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for patients without a fully human leukocyte antigen (HLA)-matched dono
Externí odkaz:
https://doaj.org/article/4b69962bfcce4270819a8ca50110c0d2